Xia Luo
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 4
- Oncology 17
- Cancer Immunotherapy and Biomarkers 11
- Co-authors
- Qianjin Liao (19 shared papers)Linda Oyang (18 shared papers)Yujuan Zhou (14 shared papers)Yanyan Tang (15 shared papers)Longzheng Xia (17 shared papers)Shiming Tan (16 shared papers)Jinguan Lin (15 shared papers)Yaqian Han (11 shared papers)
- Journals
- Frontiers in Pharmacology (8 papers)Advances in Therapy (4 papers)Frontiers in Oncology (4 papers)PLoS ONE (3 papers)PharmacoEconomics (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xia Luo
47 papers receiving 2.0k citations
Xia Luo's Hit Papers
Peers
Comparison fields: 5 of 93
- Cancer Research 613
- Oncology 453
- Immunology 283
- Molecular Biology 820
- Pulmonary and Respiratory Medicine 306
Countries citing papers authored by Xia Luo
This map shows the geographic impact of Xia Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Luo more than expected).
Fields of papers citing papers by Xia Luo
This network shows the impact of papers produced by Xia Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Luo. The network helps show where Xia Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xia Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cancer metabolic reprogramming and immune response Hit paper breakdown → | 2021 | 888 |
| 2 | 2019 | 131 | |
| 3 | 2019 | 91 | |
| 4 | Endoplasmic reticulum stress—a key guardian in cancer Hit paper breakdown → | 2024 | 79 |
| 5 | 2022 | 75 | |
| 6 | 2021 | 74 | |
| 7 | 2021 | 48 | |
| 8 | 2019 | 43 | |
| 9 | 2024 | 41 | |
| 10 | 2019 | 41 | |
| 11 | 2019 | 40 | |
| 12 | 2009 | 36 | |
| 13 | 2020 | 32 | |
| 14 | 2017 | 31 | |
| 15 | 2021 | 28 | |
| 16 | 2020 | 28 | |
| 17 | 2019 | 26 | |
| 18 | 2020 | 22 | |
| 19 | 2021 | 20 | |
| 20 | 2022 | 19 |
About Xia Luo
Xia Luo is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Economics and Econometrics, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Economic and Financial Impacts of Cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (613 citations), Oncology (453 citations), Immunology (283 citations), Molecular Biology (820 citations) and Pulmonary and Respiratory Medicine (306 citations). Xia Luo has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Qianjin Liao, Linda Oyang, Yujuan Zhou, Yanyan Tang, Longzheng Xia, Shiming Tan, Jinguan Lin, Yaqian Han, Jiaxin Liang and Nayiyuan Wu. Their work appears in journals such as Frontiers in Pharmacology, Advances in Therapy, Frontiers in Oncology, PLoS ONE and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.